Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients

Autoimmunity Reviews

Volumn 16, Issue 7, 2017, Pages 743-749

  Gavand, Pierre Edouard ^a   Serio, Ilaria ^b   Arnaud, Laurent ^a   Costedoat Chalumeau, Nathalie ^c,d   Carvelli, Julien ^e   Dossier, Antoine ^f   Hinschberger, Olivier ^g   Mouthon, Luc ^c   Le Guern, Véronique ^c,d   Korganow, Anne Sophie ^a   Poindron, Vincent ^a   Gourguechon, Clément ^h   Lavigne, Christian ^h   Maurier, François ⁱ   Labro, Guylaine ^j   Heymonet, Marie ^k   Artifoni, Matthieu ^m   Viau, Amélie Brabant ^l   Deligny, Cristophe ⁿ   Sene, Thomas ^o   Terriou, Louis ^p   Sibilia, Jean ^a   Mathian, Alexis ^q   Bloch Queyrat, Coralie ^r   Larroche, Claire ^s   Amoura, Zahir ^q   Martin, Thierry ^a   more..

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Institut Cochin   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HÔPITAL DE LA CONCEPTION   (France)

^f BICHAT HOSPITAL   (France)

^g Service de médecine interne   (France)

^h AMIENS UNIVERSITY HOSPITAL   (France)

ⁱ Service de médecine interne   (France)

^j UNIVERSITY HOSPITAL OF BESANÇON   (France)

^k UNIVERSITY HOSPITAL OF NANCY   (France)

^l REIMS UNIVERSITY HOSPITAL   (France)

^m NANTES UNIVERSITY HOSPITAL   (France)

ⁿ CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^o GROUPE HOSPITALIER DIACONESSES CROIX SAINT SIMON   (France)

^p LILLE UNIVERSITY HOSPITAL   (France)

^q PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^r AVICENNE HOSPITAL   (France)

^s CHU Avicenne (AP HP)   (France)

more..

Author keywords

Macrophage activation syndrome; Systemic lupus erythematosus

Indexed keywords

ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BELIMUMAB; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FERRITIN; HEMOGLOBIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISOLONE; PREDNISONE; PROCALCITONIN; RITUXIMAB; STEROID; TOCILIZUMAB; TRIACYLGLYCEROL;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANEMIA; ANTIVIRAL THERAPY; ARTHRITIS; ASEPTIC MENINGITIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHIKUNGUNYA; CONFUSION; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DRUG EFFICACY; DRUG MEGADOSE; ENTEROCOCCAL INFECTION; ESCHERICHIA COLI INFECTION; FEMALE; FERRITIN BLOOD LEVEL; FEVER; HEMOGLOBIN BLOOD LEVEL; HISTOPLASMOSIS; HOSPITALIZATION; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; INFECTIOUS ARTHRITIS; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; MACROPHAGE ACTIVATION SYNDROME; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; NEUTROPENIA; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PANCREATITIS; PERICARDITIS; PNEUMOCYSTIS; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PROTEIN BLOOD LEVEL; RASH; REMISSION; RETROSPECTIVE STUDY; REVIEW; SALMONELLOSIS; SEIZURE; SOMNOLENCE; SPLENOMEGALY; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS INFECTION; STEROID THERAPY; STRONGYLOIDIASIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD; YOUNG ADULT; COMPLICATION;

HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGE ACTIVATION SYNDROME;

EID: 85020234861     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2017.05.010     Document Type: Review

References (52)

1. Schram, A.M., Berliner, N., How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood 125:19 (May 7 2015), 2908–2914.
2. Ramos-Casals, M., Brito-Zerón, P., López-Guillermo, A., Khamashta, M.A., Bosch, X., Adult haemophagocytic syndrome. Lancet Lond Engl 383:9927 (Apr 26 2014), 1503–1516.
3. Janka, G.E., Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 140:3 (Jul 1983), 221–230.
4. Henter, J.-I., Horne, A., Aricó, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:2 (Feb 2007), 124–131.
5. Chandrakasan, S., Filipovich, A.H., Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment. J Pediatr 163:5 (Nov 2013), 1253–1259.
6. Henter, J.-I., Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis. Med Pediatr Oncol 38:5 (May 2002), 305–309.
7. Maakaroun, N.R., Moanna, A., Jacob, J.T., Albrecht, H., Viral infections associated with haemophagocytic syndrome. Rev Med Virol 20:2 (Mar 2010), 93–105.
8. Janka, G., Imashuku, S., Elinder, G., Schneider, M., Henter, J.I., Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 12:2 (Apr 1998), 435–444.
9. Bae, C.-B., Jung, J.-Y., Kim, H.-A., Suh, C.-H., Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. Medicine (Baltimore), 94(4), Jan 2015, e451.
10. Kumakura, S., Murakawa, Y., Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol Hoboken NJ 66:8 (Aug 2014), 2297–2307.
11. Arlet, J.-B., Le, T.H.D., Marinho, A., Amoura, Z., Wechsler, B., Papo, T., et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis 65:12 (Dec 2006), 1596–1601.
12. Pringe, A., Trail, L., Ruperto, N., Buoncompagni, A., Loy, A., Breda, L., et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?. Lupus 16:8 (2007), 587–592.
13. Lambotte, O., Khellaf, M., Harmouche, H., Bader-Meunier, B., Manceron, V., Goujard, C., et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus- associated hemophagocytic syndrome. Medicine (Baltimore) 85:3 (May 2006), 169–182.
14. Ruscitti, P., Cipriani, P., Ciccia, F., Masedu, F., Liakouli, V., Carubbi, F., et al. Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: analysis of 41 cases collected in 2 rheumatologic centers. Autoimmun Rev 16:1 (Jan 2017), 16–21.
15. Hochberg, M.C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 40(9), Sep 1997, 1725.
16. Parodi, A., Davì, S., Pringe, A.B., Pistorio, A., Ruperto, N., Magni-Manzoni, S., et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 60:11 (Nov 2009), 3388–3399.
17. Piga, M., Vacca, A., Porru, G., Cauli, A., Mathieu, A., Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis. Clin Exp Rheumatol 28:4 (Aug 2010), 504–510.
18. Eberhard, O.K., Haubitz, M., Brunkhorst, F.M., Kliem, V., Koch, K.M., Brunkhorst, R., Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 40:7 (Jul 1997), 1250–1256.
19. Quintana, G., Medina, Y.F., Rojas, C., Fernandez, A., Restrepo, J.F., Rondon, F., et al. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 14:3 (Jun 2008), 138–142.
20. Lanoix, J.P., Bourgeois, A.M., Schmidt, J., Desblache, J., Salle, V., Smail, A., et al. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus. Lupus 20:2 (Feb 2011), 125–130.
21. Bador, K.M., Intan, S., Hussin, S., Gafor, A.H.A., Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus. Lupus 21:11 (Oct 2012), 1172–1177.
22. Sciascia, S., Ceberio, L., Garcia-Fernandez, C., Roccatello, D., Karim, Y., Cuadrado, M.J., Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers. Autoimmun Rev 12:2 (Dec 2012), 157–163.
23. Beça, S., Rodríguez-Pintó, I., Alba, M.A., Cervera, R., Espinosa, G., Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever. Autoimmun Rev 14:7 (Jul 2015), 586–593.
24. Larroche, C., Mouthon, L., Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 3:2 (Feb 2004), 69–75.
25. Liapis, K., Apostolidis, J., Delimpasis, S., EBV-associated hemophagocytic syndrome. Am J Hematol, 86(5), May 2011, 422.
26. Zhang, Z., Wang, J., Ji, B., Bahr Greenwood, T. von, Zhang, Y., Wang, Y., et al. Clinical presentation of hemophagocytic lymphohistiocytosis in adults is less typical than in children. Clinics (Sao Paulo) 71:4 (Apr 2016), 205–209.
27. Larsen, M., Sauce, D., Deback, C., Arnaud, L., Mathian, A., Miyara, M., et al. Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog, 7(10), Oct 2011, e1002328.
28. Schram, A.M., Comstock, P., Campo, M., Gorovets, D., Mullally, A., Bodio, K., et al. Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years. Br J Haematol 172:3 (Feb 2016), 412–419.
29. Otrock, Z.K., Eby, C.S., Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 90:3 (Mar 2015), 220–224.
30. Fukaya, S., Yasuda, S., Hashimoto, T., Oku, K., Kataoka, H., Horita, T., et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 47:11 (Nov 2008), 1686–1691.
31. Watanabe, H., Hirase, N., Goda, H., Nishikawa, H., Ikuyama, S., Oral low-dose tacrolimus therapy for refractory hemophagocytic syndrome associated with systemic lupus erythematosus. Mod Rheumatol 22:2 (Apr 2012), 284–289.
32. Emmenegger, U., Spaeth, P.J., Neftel, K.A., Intravenous immunoglobulin for hemophagocytic lymphohistiocytosis?. J Clin Oncol Off J Am Soc Clin Oncol 20:2 (Jan 15 2002), 599–601.
33. Larroche, C., Bruneel, F., André, M.H., Bader-Meunier, B., Baruchel, A., Tribout, B., et al. Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP. Ann Med Interne (Paris) 151:7 (Nov 2000), 533–539.
34. Matsumoto, Y., Naniwa, D., Banno, S., Sugiura, Y., The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports. Ther Apher Off J Int Soc Apher Jpn Soc Apher 2:4 (Nov 1998), 300–304.
35. Takahashi, N., Naniwa, T., Banno, S., Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome. Mod Rheumatol 18:1 (2008), 72–75.
36. Henzan, T., Nagafuji, K., Tsukamoto, H., Miyamoto, T., Gondo, H., Imashuku, S., et al. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol 81:1 (Jan 2006), 59–61.
37. Marsh, R.A., Allen, C.E., McClain, K.L., Weinstein, J.L., Kanter, J., Skiles, J., et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer 60:1 (Jan 2013), 101–109.
38. Abdallah, M., B'Chir Hamzaoui, S., Bouslama, K., Mestiri, H., Harmel, A., Ennafaa, M., et al. Acute pancreatitis associated with hemophagocytic syndrome in systemic lupus erythematous: a case report. Gastroenterol Clin Biol 29:10 (Oct 2005), 1054–1056.
39. Ideguchi, H., Ohno, S., Takase, K., Hattori, H., Kirino, Y., Takeno, M., et al. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. Rheumatology (Oxford) 46:10 (Oct 2007), 1621–1622.
40. Qian, J., Yang, C.-D., Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: two case reports and literature review. Clin Rheumatol 26:5 (May 2007), 807–810.
41. Pérard, L., Costedoat-Chalumeau, N., Limal, N., Hot, A., Cohen, J., Vauthier-Brouzes, D., et al. Hemophagocytic syndrome in a pregnant patient with systemic lupus erythematosus, complicated with preeclampsia and cerebral hemorrhage. Ann Hematol 86:7 (Jul 2007), 541–544.
42. Silva, D. da F.R., Anunciação, F.A.C., Arcoverde, J. da C., Costa, L.P., Marques, I.D.B., Pinheiro, G. da S., et al. Hemophagocytic syndrome: a clinical presentation of systemic lupus erythematosus. Acta Reumatol Port 33:1 (Mar 2008), 91–97.
43. Takizawa, Y., Maruyama, J., Setoguchi, K., Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin. Scand J Rheumatol 38:6 (Dec 2009), 492–494.
44. Taki, H., Shinoda, K., Hounoki, H., Ogawa, R., Hayashi, R., Sugiyama, E., et al. Presenting manifestations of hemophagocytic syndrome in a male patient with systemic lupus erythematosus. Rheumatol Int 30:3 (Jan 2010), 387–388.
45. Kamiya, K., Kurasawa, K., Arai, S., Maezawa, R., Hanaoka, R., Kumano, K., et al. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus. Mod Rheumatol 20:1 (Feb 2010), 81–85.
46. Carvalheiras, G., Anjo, D., Mendonça, T., Vasconcelos, C., Farinha, F., Hemophagocytic syndrome as one of the main primary manifestations in acute systemic lupus erythematosus — case report and literature review. Lupus 19:6 (May 2010), 756–761.
47. Elqatni, M., Mekouar, F., Sekkach, Y., Elomri, N., Fatihi, J., Amezyane, T., et al. Haemophagocytic syndrome as a complication of acute pancreatitis during systemic lupus erythematosus. Ann Dermatol Venereol 139:1 (Jan 2012), 46–49.
48. Uttenthal, B.J., Layton, D.M., Vyse, T.J., Schreiber, B.E., Clinical problem-solving. The wolf at the door. N Engl J Med 366:23 (Jun 7 2012), 2216–2221.
49. Kikuchi, H., Yamamoto, T., Asako, K., Takayama, M., Shirasaki, R., Ono, Y., Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus. Mod Rheumatol 22:2 (Apr 2012), 308–311.
50. Keith, M.P., Pitchford, C., Bernstein, W.B., Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 18:3 (Apr 2012), 134–137.
51. Ueda, Y., Yamashita, H., Takahashi, Y., Kaneko, H., Kano, T., Mimori, A., Refractory hemophagocytic syndrome in systemic lupus erythematosus successfully treated with intermittent intravenous cyclophosphamide: three case reports and literature review. Clin Rheumatol 33:2 (Feb 2014), 281–286.
52. Bakshi, J., Hassan, S., D'Cruz, D., Chan, A., Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus. Lupus 22:14 (Dec 2013), 1544–1546.